Table 3.
Variable | 25-hydroxyvitamin D (ng/mL) |
||||
---|---|---|---|---|---|
Simple linear regression analysis |
Multiple linear stepwise regression analysis |
||||
R | P-value | β (95% CI) | t-value | P-value | |
Age, yr | −0.12 | 0.05 | - | 0.41 | 0.68 |
Lumbar spine BMD, g/cm2 | 0.06 | 0.19 | - | −0.62 | 0.54 |
Femoral neck BMD, g/cm2 | 0.20 | <0.001 | 0.16 (0.78–12.17) | 2.24 | 0.03 |
Albumin, g/dL | 0.24 | <0.001 | 0.21 (0.62–2.96) | 3.01 | <0.001 |
Albumin-corrected calcium, mg/dL | 0.04 | 0.29 | - | 1.21 | 0.23 |
Phosphate, mg/dL | 0.07 | 0.15 | - | 0.98 | 0.33 |
Tartrate-resistant acid phosphatase 5b, mU/dL | −0.15 | 0.02 | - | −1.37 | 0.17 |
Undercarboxylated osteocalcin, ng/mL | −0.08 | 0.12 | - | −0.86 | 0.39 |
Existing fragility fracture | - | - | - | −1.56 | 0.12 |
Fracture site | |||||
Vertebral fracture | - | - | - | 1.57 | 0.12 |
Hip fracture | - | - | - | −1.67 | 0.10 |
Distal radius fracture | - | - | - | 0.17 | 0.87 |
Proximal humerus fracture | - | - | - | −0.32 | 0.75 |
Place of residence | |||||
Home | - | - | - | −0.27 | 0.79 |
Hospital | - | - | - | −0.83 | 0.41 |
Facility | - | - | - | 0.78 | 0.44 |
R = correlation coefficient; β = standardized correlation coefficients (95% confidence interval [CI]); BMD, bone mineral density.